HOME › DRUGS › PREPANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)
ACTIVE SUBSTANCE / INN

PREPANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)

Brand name(s): Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics
EMA LISTED
EXPIRED
Influenza, Human;Immunization;Disease Outbreaks
ACTIVE SUBSTANCE
Prepandemic Influenza Vaccine (H5N1) (Surface Antigen, Inactivated, Adjuvanted)
REGULATORS
EMA
SPONSORS / MAH
Novartis Vaccines and Diagnostics S.r.l.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and DiagnosticsNovartis Vaccines and Diagnostics S.r.l.Expired29/11/2010Influenza, Human;Immunization;Disease Outbreaks

FULL INTELLIGENCE ON PREPANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →